Tech Company Financing Transactions
Western Oncolytics Funding Round
Western Oncolytics, based in Pittsburgh, secured $2.5 million from private investors.
Transaction Overview
Company Name
Announced On
6/5/2015
Transaction Type
Venture Equity
Amount
$2,500,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
265 William Pitt Way
Pittsburgh, PA 15238
USA
Pittsburgh, PA 15238
USA
Phone
Website
Email Address
Overview
Western Oncolytics Ltd. develops therapies for cancer. It develops WO-12, an immuno-oncolytic therapy that stimulates a directed immune attack against cancer while removing blocks to immune activity in tumor environments, as well as works in combination with other therapies.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Stephen Thorne
Chief Financial Officer
Ian Magazine
Chief Operating Officer
Helena Chaye
VP - Bus. Development
Katy Wack
VP - General Counsel
Elizabeth Duckett
Browse more venture capital transactions:
Prev: 6/5/2015: Springbot venture capital transaction
Next: 6/5/2015: Ioxus venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to record every notable VC transaction. VC transactions on this site are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs